| 1 | Lifestyle, medication use, and age considerations with acne vulgaris: A prospective study | 0.5 | 0 | Citations (PDF) |
| 2 | Vision Loss and Blindness in the United States: An Age-Adjusted Comparison by Sex and Associated Disease Category | 4.3 | 3 | Citations (PDF) |
| 3 | Semiparametric joint modeling to estimate the treatment effect on a longitudinal surrogate with application to chronic kidney disease trials | 1.6 | 0 | Citations (PDF) |
| 4 | Role of Age and Competing Risk of Death in the Racial Disparity of Kidney Failure Incidence after Onset of CKD | 0.4 | 6 | Citations (PDF) |
| 5 | Comparing Bayesian hierarchical meta-regression methods and evaluating the influence of priors for evaluations of surrogate endpoints on heterogeneous collections of clinical trials | 2.5 | 2 | Citations (PDF) |
| 6 | 0017 Circadian Phase Alignment and Sleep Duration in Overweight Adults: Associations with Cardiometabolic Risk Factors | 0.9 | 2 | Citations (PDF) |
| 7 | History of stroke as a predictor of high left atrial fibrosis in patients with persistent atrial fibrillation—insight from the DECAAF II randomized trial | 1.9 | 3 | Citations (PDF) |
| 8 | Predicting kidney graft function and failure among kidney transplant recipients | 2.5 | 4 | Citations (PDF) |
| 9 | Which veterans in the Supportive Services for Veteran Families program receive temporary financial assistance and why: a mixed methods study | 1.6 | 5 | Citations (PDF) |
| 10 | The Effectiveness of a Mindfulness-Based Intervention Integrated with Physical Therapy (MIND-PT) for Postsurgical Rehabilitation After Lumbar Surgery: A Protocol for a Randomized Controlled Trial as Part of the Back Pain Consortium (BACPAC) Research Program | 2.0 | 3 | Citations (PDF) |
| 11 | Predicting the risk of a clinical event using longitudinal data: the generalized landmark analysis | 2.5 | 20 | Citations (PDF) |
| 12 | Characterizing modifications to a comparative effectiveness research study: the OPTIMIZE trial—using the Framework for Reporting Adaptations and Modifications to Evidence-based Interventions (FRAME) | 2.0 | 3 | Citations (PDF) |
| 13 | Change in Albuminuria and GFR Slope as Joint Surrogate End Points for Kidney Failure: Implications for Phase 2 Clinical Trials in CKD | 0.4 | 24 | Citations (PDF) |
| 14 | Estimating the optimal individualized treatment rule from a cost‐effectiveness perspective | 1.6 | 10 | Citations (PDF) |
| 15 | Biased estimation with shared parameter models in the presence of competing dropout mechanisms | 1.6 | 8 | Citations (PDF) |
| 16 | Effectiveness of training physical therapists in pain neuroscience education for patients with chronic spine pain: a cluster-randomized trial | 4.2 | 23 | Citations (PDF) |
| 17 | Changes in Pain Catastrophizing and Fear-Avoidance Beliefs as Mediators of Early Physical Therapy on Disability and Pain in Acute Low-Back Pain: A Secondary Analysis of a Clinical Trial | 2.0 | 15 | Citations (PDF) |
| 18 | Safety and efficacy of dapagliflozin in patients with focal segmental glomerulosclerosis: a prespecified analysis of the dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial | 0.8 | 96 | Citations (PDF) |
| 19 | Acute Treatment Effects on GFR in Randomized Clinical Trials of Kidney Disease Progression | 0.4 | 30 | Citations (PDF) |
| 20 | N-myristoyltransferase 2–based Blood Test for the Detection of Colorectal Adenomatous Polyps and Cancer | 1.4 | 0 | Citations (PDF) |
| 21 | Potential Effects of Elimination of the Black Race Coefficient in eGFR Calculations in the CREDENCE Trial | 4.2 | 15 | Citations (PDF) |
| 22 | Letter by Inker et al Regarding Article, “Pitfalls in Using Estimated Glomerular Filtration Rate Slope as a Surrogate for the Effect of Drugs on the Risk of Serious Adverse Renal Outcomes in Clinical Trials of Patients With Heart Failure” | 4.4 | 3 | Citations (PDF) |
| 23 | Association between unmet medication needs after hospital discharge and readmission or death among acute respiratory failure survivors: the addressing post-intensive care syndrome (APICS-01) multicenter prospective cohort study | 6.0 | 18 | Citations (PDF) |
| 24 | Analysis of Therapeutic Inertia and Race and Ethnicity in the Systolic Blood Pressure Intervention Trial: A Secondary Analysis of a Randomized Clinical Trial | 6.6 | 26 | Citations (PDF) |
| 25 | Association of Antihypertensives That Stimulate vs Inhibit Types 2 and 4 Angiotensin II Receptors With Cognitive Impairment | 6.6 | 46 | Citations (PDF) |
| 26 | Effect of MRI-Guided Fibrosis Ablation vs Conventional Catheter Ablation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation | 16.5 | 397 | Citations (PDF) |
| 27 | Risk of Mild Cognitive Impairment or Probable Dementia in New Users of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors | 6.6 | 16 | Citations (PDF) |
| 28 | Correlates and Consequences of an Acute Change in eGFR in Response to the SGLT2 Inhibitor Dapagliflozin in Patients with CKD | 0.4 | 88 | Citations (PDF) |
| 29 | An efficient approach for optimizing the cost-effective individualized treatment rule using conditional random forest | 1.6 | 4 | Citations (PDF) |
| 30 | Depression and CKD as Risk Factors of Heart Failure: Post Hoc Analysis of SPRINT | 0.4 | 0 | Citations (PDF) |
| 31 | Effect of Dapagliflozin on Clinical Outcomes in Patients With Chronic Kidney Disease, With and Without Cardiovascular Disease | 18.0 | 121 | Citations (PDF) |
| 32 | Physical Therapy Referral From Primary Care for Acute Back Pain With Sciatica | 9.6 | 40 | Citations (PDF) |
| 33 | Hydroxychloroquine versus Azithromycin for Hospitalized Patients with COVID-19. Results of a Randomized, Active Comparator Trial | 3.4 | 36 | Citations (PDF) |
| 34 | Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice | 5.3 | 156 | Citations (PDF) |
| 35 | Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial | 21.7 | 497 | Citations (PDF) |
| 36 | Association of Temporary Financial Assistance With Housing Stability Among US Veterans in the Supportive Services for Veteran Families Program | 6.6 | 21 | Citations (PDF) |
| 37 | Kidney, Cardiovascular, and Safety Outcomes of Canagliflozin according to Baseline Albuminuria | 4.2 | 51 | Citations (PDF) |
| 38 | Chronic kidney disease, atherosclerotic plaque characteristics on carotid magnetic resonance imaging, and cardiovascular outcomes | 2.1 | 9 | Citations (PDF) |
| 39 | Reply to “The Problem of Collinearity in Mental Health and Patient Reported Outcome Research” | 1.4 | 2 | Citations (PDF) |
| 40 | Efficacy of LGE‐MRI‐guided fibrosis ablation versus conventional catheter ablation of atrial fibrillation: The DECAAF II trial: Study design | 2.1 | 84 | Citations (PDF) |
| 41 | Heart Failure Hospitalization Risk associated with Iron Status in Veterans with CKD | 4.2 | 27 | Citations (PDF) |
| 42 | Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial | 2.2 | 111 | Citations (PDF) |
| 43 | Patient Selection for Intensive Blood Pressure Management Based on Benefit and Adverse Events | 2.3 | 44 | Citations (PDF) |
| 44 | Targeting Sedentary Behavior in CKD | 4.2 | 22 | Citations (PDF) |
| 45 | Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans | 2.3 | 17 | Citations (PDF) |
| 46 | Temporary Financial Assistance Decreased Health Care Costs For Veterans Experiencing Housing Instability | 5.1 | 20 | Citations (PDF) |
| 47 | A New Panel-Estimated GFR, Including β2-Microglobulin and β-Trace Protein and Not Including Race, Developed in a Diverse Population | 1.4 | 68 | Citations (PDF) |
| 48 | A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy | 5.3 | 386 | Citations (PDF) |
| 49 | Association of Treatment Effects on Early Change in Urine Protein and Treatment Effects on GFR Slope in IgA Nephropathy: An Individual Participant Meta-analysis | 1.4 | 93 | Citations (PDF) |
| 50 | New Creatinine- and Cystatin C–Based Equations to Estimate GFR without Race | 34.5 | 4,067 | Citations (PDF) |
| 51 | Application of community – engaged dissemination and implementation science to improve health equity | 1.6 | 56 | Citations (PDF) |
| 52 | Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial | 21.7 | 184 | Citations (PDF) |
| 53 | Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial | 21.7 | 189 | Citations (PDF) |
| 54 | Probability-Based Estimates of Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Detection Fraction, Utah, USA | 3.8 | 10 | Citations (PDF) |
| 55 | High variability in transmission of SARS-CoV-2 within households and implications for control | 2.3 | 16 | Citations (PDF) |
| 56 | Social Determinants of Health and Estimated GFR in the MDRD Study | 0.4 | 0 | Citations (PDF) |
| 57 | Should You Follow the Better‐Hearing Ear for Congenital Cytomegalovirus Infection and Isolated Sensorineural Hearing Loss? | 2.3 | 21 | Citations (PDF) |
| 58 | Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease According to Baseline HbA1c, Including Those With HbA1c <7% | 18.0 | 115 | Citations (PDF) |
| 59 | Early Change in Albuminuria with Canagliflozin Predicts Kidney and Cardiovascular Outcomes: A Post Hoc Analysis from the CREDENCE Trial | 0.4 | 154 | Citations (PDF) |
| 60 | Clinical predictors for etiology of acute diarrhea in children in resource-limited settings | 3.0 | 28 | Citations (PDF) |
| 61 | Factors That Contribute to Cost Differences Based on ICU of Admission in Neonates Undergoing Congenital Heart Surgery: A Novel Decomposition Analysis | 2.4 | 5 | Citations (PDF) |
| 62 | Dapagliflozin in Patients with Chronic Kidney Disease | 34.5 | 5,035 | Citations (PDF) |
| 63 | Effects of Canagliflozin in Patients with Baseline eGFR <30 ml/min per 1.73 m2 | 4.2 | 135 | Citations (PDF) |
| 64 | Evaluating the association between unmet healthcare needs and subsequent clinical outcomes: protocol for the Addressing Post-Intensive Care Syndrome-01 (APICS-01) multicentre cohort study | 1.9 | 18 | Citations (PDF) |
| 65 | Patient‐reported outcomes and subsequent management in atrial fibrillation clinical practice: Results from the Utah mEVAL AF program | 2.1 | 13 | Citations (PDF) |
| 66 | The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics | 0.8 | 171 | Citations (PDF) |
| 67 | Comparison of As-Needed and Scheduled Posthospitalization Follow-up for Children Hospitalized for Bronchiolitis | 8.5 | 24 | Citations (PDF) |
| 68 | Improving Care for Patients after Hospitalization with AKI | 0.4 | 41 | Citations (PDF) |
| 69 | Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) | 1.8 | 0 | Citations (PDF) |
| 70 | The Influence of Baseline Diastolic Blood Pressure on the Effects of Intensive Blood Pressure Lowering on Cardiovascular Outcomes and All-Cause Mortality in Type 2 Diabetes | 6.2 | 45 | Citations (PDF) |
| 71 | Renal, Cardiovascular, and Safety Outcomes of Canagliflozin by Baseline Kidney Function: A Secondary Analysis of the CREDENCE Randomized Trial | 0.4 | 149 | Citations (PDF) |
| 72 | Sodium Bicarbonate Supplementation and Urinary TGF-β1 in Nonacidotic Diabetic Kidney Disease | 4.2 | 25 | Citations (PDF) |
| 73 | Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial | 0.8 | 204 | Citations (PDF) |
| 74 | Empirical Anti-MRSA vs Standard Antibiotic Therapy and Risk of 30-Day Mortality in Patients Hospitalized for Pneumonia | 10.6 | 112 | Citations (PDF) |
| 75 | Drug Development in Kidney Disease: Proceedings From a Multistakeholder Conference | 1.4 | 5 | Citations (PDF) |
| 76 | Unilateral versus bilateral hilar stents for the treatment of cholangiocarcinoma: a multicenter international study | 0.5 | 17 | Citations (PDF) |
| 77 | Baseline Diastolic Blood Pressure and Cardiovascular Outcomes in SPRINT Participants with Chronic Kidney Disease | 1.8 | 7 | Citations (PDF) |
| 78 | Early GFR Decline with Intensive BP Lowering and the Risk of Death and ESKD: Mediation Analysis of AASK Study | 0.4 | 0 | Citations (PDF) |
| 79 | Propensity score weighting analysis and treatment effect discovery | 1.6 | 108 | Citations (PDF) |
| 80 | Performance of GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Statistical Simulation | 0.4 | 113 | Citations (PDF) |
| 81 | Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups | 18.0 | 254 | Citations (PDF) |
| 82 | Implications of Early Decline in eGFR due to Intensive BP Control for Cardiovascular Outcomes in SPRINT | 0.4 | 56 | Citations (PDF) |
| 83 | Influence of Prediabetes on the Effects of Intensive Systolic Blood Pressure Control on Kidney Events | 2.0 | 6 | Citations (PDF) |
| 84 | Mixed‐effects models for slope‐based endpoints in clinical trials of chronic kidney disease | 1.7 | 71 | Citations (PDF) |
| 85 | Association of Total Medication Burden With Intensive and Standard Blood Pressure Control and Clinical Outcomes: A Secondary Analysis of SPRINT | 6.6 | 28 | Citations (PDF) |
| 86 | The authors reply | 5.3 | 0 | Citations (PDF) |
| 87 | GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Meta-Analysis of Treatment Effects of Randomized Controlled Trials | 0.4 | 298 | Citations (PDF) |
| 88 | Strengths and limitations of estimated and measured GFR | 32.8 | 54 | Citations (PDF) |
| 89 | An increased mortality risk is associated with abnormal iron status in diabetic and non-diabetic Veterans with predialysis chronic kidney disease | 5.3 | 59 | Citations (PDF) |
| 90 | Ambulatory Management of Childhood Asthma Using a Novel Self-management Application | 4.5 | 24 | Citations (PDF) |
| 91 | Mineral Metabolism Disturbances and Arteriovenous Fistula Maturation | 1.9 | 20 | Citations (PDF) |
| 92 | The TiME Trial: A Fully Embedded, Cluster-Randomized, Pragmatic Trial of Hemodialysis Session Duration | 0.4 | 58 | Citations (PDF) |
| 93 | Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy | 34.5 | 5,640 | Citations (PDF) |
| 94 | Comparative Efficacy of Therapies for Treatment of Depression for Patients Undergoing Maintenance Hemodialysis | 9.6 | 105 | Citations (PDF) |
| 95 | Contextual Factors Influencing Implementation of Evidence-Based Care for Children Hospitalized With Asthma | 1.5 | 2 | Citations (PDF) |
| 96 | Long-term hearing outcomes of children with symptomatic congenital CMV treated with valganciclovir | 1.2 | 38 | Citations (PDF) |
| 97 | The Familiality of Rapid Renal Decline in Diabetes | 4.2 | 14 | Citations (PDF) |
| 98 | Deceased-donor acute kidney injury is not associated with kidney allograft failure | 5.3 | 84 | Citations (PDF) |
| 99 | Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies | 21.7 | 303 | Citations (PDF) |
| 100 | Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials | 21.7 | 360 | Citations (PDF) |
| 101 | Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium | 1.4 | 76 | Citations (PDF) |
| 102 | Metabolomic profiling to improve glomerular filtration rate estimation: a proof-of-concept study | 0.8 | 50 | Citations (PDF) |
| 103 | Evaluating instrument responsiveness in joint function: The HOOS JR, the KOOS JR, and the PROMIS PF CAT | 2.4 | 73 | Citations (PDF) |
| 104 | Impact of Implementing Antibiotic Stewardship Programs in 15 Small Hospitals: A Cluster-Randomized Intervention | 5.2 | 77 | Citations (PDF) |
| 105 | Intensive systolic blood pressure control and incident chronic kidney disease in people with and without diabetes mellitus: secondary analyses of two randomised controlled trials | 21.7 | 118 | Citations (PDF) |
| 106 | Relationships Between Clinical Processes and Arteriovenous Fistula Cannulation and Maturation: A Multicenter Prospective Cohort Study | 1.4 | 83 | Citations (PDF) |
| 107 | Benefits and risks of intensive blood‐pressure lowering in advanced chronic kidney disease | 7.3 | 6 | Citations (PDF) |
| 108 | Increasing Mortality in Adults With Diabetes and Low Estimated Glomerular Filtration Rate in the Absence of Albuminuria | 6.2 | 56 | Citations (PDF) |
| 109 | Comparative analysis of the safety and efficacy of intracameral cefuroxime, moxifloxacin and vancomycin at the end of cataract surgery: a meta-analysis | 3.8 | 114 | Citations (PDF) |
| 110 | Patterns of Kidney Function Decline in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis From the HALT-PKD Trials | 1.4 | 42 | Citations (PDF) |
| 111 | Relationship of Sodium Intake and Blood Pressure Varies With Energy Intake | 6.6 | 54 | Citations (PDF) |
| 112 | Overcoming Translational Barriers in Acute Kidney Injury | 4.2 | 38 | Citations (PDF) |
| 113 | A simple method to estimate the time-dependent receiver operating characteristic curve and the area under the curve with right censored data | 1.6 | 67 | Citations (PDF) |
| 114 | Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure Control | 18.0 | 163 | Citations (PDF) |
| 115 | Association between Urine Ammonium and Urine TGF-β1 in CKD | 4.2 | 20 | Citations (PDF) |
| 116 | Longitudinal Estimated GFR Trajectories in Patients With and Without Type 2 Diabetes and Nephropathy | 1.4 | 64 | Citations (PDF) |
| 117 | Susceptibilities of clinical Clostridium difficile isolates to antimicrobials: a systematic review and meta-analysis of studies since 1970 | 5.3 | 23 | Citations (PDF) |
| 118 | Longitudinal Analysis of Erythrocyte and Plasma Protoporphyrin Levels in Patients with Protoporphyria | 1.3 | 6 | Citations (PDF) |
| 119 | In Data We Trust? Comparison of Electronic Versus Manual Abstraction of Antimicrobial Prescribing Quality Metrics for Hospitalized Veterans With Pneumonia | 1.8 | 13 | Citations (PDF) |
| 120 | Effects of Intensive Systolic Blood Pressure Lowering on Cardiovascular Events and Mortality in Patients With Type 2 Diabetes Mellitus on Standard Glycemic Control and in Those Without Diabetes Mellitus: Reconciling Results From ACCORD BP and SPRINT | 4.0 | 114 | Citations (PDF) |
| 121 | Prediction of Arteriovenous Fistula Clinical Maturation from Postoperative Ultrasound Measurements: Findings from the Hemodialysis Fistula Maturation Study | 0.4 | 168 | Citations (PDF) |
| 122 | Clinical and Economic Outcomes of Ranolazine Versus Conventional Antianginals Users Among Veterans With Chronic Stable Angina Pectoris | 1.8 | 4 | Citations (PDF) |
| 123 | Health Related Quality of Life in Heart Failure Patients with Improved Ejection Fraction | 1.8 | 1 | Citations (PDF) |
| 124 | Biological Variability of Estimated GFR and Albuminuria in CKD | 1.4 | 110 | Citations (PDF) |
| 125 | Response by Beddhu et al to Letters Regarding Article, “Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure Control” | 18.0 | 6 | Citations (PDF) |
| 126 | Patients receiving frequent hemodialysis have better health-related quality of life compared to patients receiving conventional hemodialysis | 5.3 | 93 | Citations (PDF) |
| 127 | Comparative Effectiveness of Vancomycin and Metronidazole for the Prevention of Recurrence and Death in Patients With Clostridium difficile Infection | 10.6 | 163 | Citations (PDF) |
| 128 | Predictors of 6-month health utility outcomes in survivors of acute respiratory distress syndrome | 5.6 | 35 | Citations (PDF) |
| 129 | Associations of Dietary Protein and Energy Intakes With Protein-Energy Wasting Syndrome in Hemodialysis Patients | 2.5 | 15 | Citations (PDF) |
| 130 | Effects of Intensive BP Control in CKD | 0.4 | 477 | Citations (PDF) |
| 131 | Cardiac Stress Testing during Workup for Abdominal Aortic Aneurysm Repair Is Not Associated with Improved Patient Outcomes | 1.1 | 10 | Citations (PDF) |
| 132 | Associations of Protein−Energy Wasting Syndrome Criteria With Body Composition and Mortality in the General and Moderate Chronic Kidney Disease Populations in the United States | 2.5 | 26 | Citations (PDF) |
| 133 | Urine Ammonium Predicts Clinical Outcomes in Hypertensive Kidney Disease | 0.4 | 95 | Citations (PDF) |
| 134 | Subgroup Selection in Adaptive Signature Designs of Confirmatory Clinical Trials | 1.0 | 28 | Citations (PDF) |
| 135 | Functional Outcome After Intracranial Pressure Monitoring for Children With Severe Traumatic Brain Injury | 8.5 | 82 | Citations (PDF) |
| 136 | Effects of Intensive Systolic Blood Pressure Control on Kidney and Cardiovascular Outcomes in Persons Without Kidney Disease | 9.6 | 110 | Citations (PDF) |
| 137 | Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease—Improving Global Outcomes (KDIGO) Controversies Conference | 5.3 | 138 | Citations (PDF) |
| 138 | Intimal Hyperplasia, Stenosis, and Arteriovenous Fistula Maturation Failure in the Hemodialysis Fistula Maturation Study | 0.4 | 143 | Citations (PDF) |
| 139 | Understanding patient outcomes after acute respiratory distress syndrome: identifying subtypes of physical, cognitive and mental health outcomes | 5.6 | 79 | Citations (PDF) |
| 140 | Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial | 6.2 | 75 | Citations (PDF) |
| 141 | Blood pressure and the risk of chronic kidney disease progression using multistate marginal structural models in the CRIC Study | 1.7 | 11 | Citations (PDF) |
| 142 | Association of Maternal Preeclampsia With Infant Risk of Premature Birth and Retinopathy of Prematurity | 6.1 | 49 | Citations (PDF) |
| 143 | Direct concurrent comparison of multiple pediatric acute asthma scoring instruments | 1.6 | 16 | Citations (PDF) |
| 144 | Anti–TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy | 0.4 | 274 | Citations (PDF) |
| 145 | Adherence rates to ferric citrate as compared to active control in patients with end stage kidney disease on dialysis | 1.1 | 6 | Citations (PDF) |
| 146 | A Dynamic Transmission Model to Evaluate the Effectiveness of Infection Control Strategies | 0.8 | 12 | Citations (PDF) |
| 147 | The responsiveness of the PROMIS instruments and the qDASH in an upper extremity population | 2.6 | 38 | Citations (PDF) |
| 148 | The safety of achieved iron stores and their effect on IV iron and ESA use: post-hoc results from a randomized trial of ferric citrate as a phosphate binder in dialysis | 0.7 | 10 | Citations (PDF) |
| 149 | Bone Mineral Density in Navajo Men and Women and Comparison to Non-Hispanic Whites from NHANES (2005–2008) | 0.7 | 1 | Citations (PDF) |
| 150 | Stewardship in Community Hospitals—Optimizing Outcomes and Resources (SCORE): A Cluster-Randomized Controlled Trial Investigating the Impact of Antibiotic Stewardship in 15 Small, Community Hospitals | 0.8 | 4 | Citations (PDF) |
| 151 | Joint multiple imputation for longitudinal outcomes and clinical events that truncate longitudinal follow‐up | 1.7 | 13 | Citations (PDF) |
| 152 | A Randomized Controlled Trial of the Effects of Febuxostat Therapy on Adipokines and Markers of Kidney Fibrosis in Asymptomatic Hyperuricemic Patients With Diabetic Nephropathy | 1.2 | 49 | Citations (PDF) |
| 153 | Neonatal Magnesium Levels Between 24 and 48 Hours of Life and Outcomes for Epilepsy and Motor Impairment in Premature Infants | 1.7 | 7 | Citations (PDF) |
| 154 | Association between Preoperative Vascular Function and Postoperative Arteriovenous Fistula Development | 0.4 | 74 | Citations (PDF) |
| 155 | Measuring the Impact of Whole-Body Computed Tomography on Hospital Length of Stay in Blunt Trauma | 2.7 | 5 | Citations (PDF) |
| 156 | Early Change in Urine Protein as a Surrogate End Point in Studies of IgA Nephropathy: An Individual-Patient Meta-analysis | 1.4 | 153 | Citations (PDF) |
| 157 | Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in CKD | 1.4 | 94 | Citations (PDF) |
| 158 | Antibiotic Use in Small Community Hospitals | 5.2 | 55 | Citations (PDF) |
| 159 | Implementation of a Value-Driven Outcomes Program to Identify High Variability in Clinical Costs and Outcomes and Association With Reduced Cost and Improved Quality | 16.5 | 275 | Citations (PDF) |
| 160 | Patterns of Kidney Function Decline Associated with APOL1 Genotypes: Results from AASK | 4.2 | 19 | Citations (PDF) |
| 161 | The Associations of Plant Protein Intake With All-Cause Mortality in CKD | 1.4 | 172 | Citations (PDF) |
| 162 | Rationale and design of A Trial of Sertraline vs. Cognitive Behavioral Therapy for End-stage Renal Disease Patients with Depression (ASCEND) | 1.6 | 46 | Citations (PDF) |
| 163 | Candidate Surrogate End Points for ESRD after AKI | 0.4 | 61 | Citations (PDF) |
| 164 | Arteriovenous Fistula Development in the First 6 Weeks after Creation | 8.7 | 126 | Citations (PDF) |
| 165 | Long-Term Effects of Frequent In–Center Hemodialysis | 0.4 | 114 | Citations (PDF) |
| 166 | GFR Estimation Using β-Trace Protein and β2-Microglobulin in CKD | 1.4 | 143 | Citations (PDF) |
| 167 | Low Vitamin D and High Fibroblast Growth Factor 23 Serum Levels Associate with Infectious and Cardiac Deaths in the HEMO Study | 0.4 | 138 | Citations (PDF) |
| 168 | Dynamic Prediction of Renal Failure Using Longitudinal Biomarkers in a Cohort Study of Chronic Kidney Disease | 0.3 | 33 | Citations (PDF) |
| 169 | Variation in Outpatient Antibiotic Prescribing for Acute Respiratory Infections in the Veteran Population | 9.6 | 101 | Citations (PDF) |
| 170 | Reducing Time-dependent Bias in Estimates of the Attributable Cost of Health Care–associated Methicillin-resistant Staphylococcus aureus Infections | 1.8 | 39 | Citations (PDF) |
| 171 | Effect of Naturally Occurring Ozone Air Pollution Episodes on Pulmonary Oxidative Stress and Inflammation | 2.9 | 34 | Citations (PDF) |
| 172 | Net endogenous acid production and mortality in NHANES III | 1.6 | 15 | Citations (PDF) |
| 173 | Efficient parameter estimation for models of healthcare-associated pathogen transmission in discrete and continuous time | 1.3 | 13 | Citations (PDF) |
| 174 | Supervised oral protein supplementation during dialysis in patients with elevated C-reactive protein levels: a two phase, longitudinal, single center, open labeled study | 2.1 | 10 | Citations (PDF) |
| 175 | Comparative Effectiveness of Oral Versus Outpatient Parenteral Antibiotic Therapy for Empyema | 1.5 | 26 | Citations (PDF) |
| 176 | Effects of frequent hemodialysis on blood pressure: Results from the randomized frequent hemodialysis network trials | 1.1 | 78 | Citations (PDF) |
| 177 | A dynamic postoperative protocol provides efficient care for pediatric patients with non-ruptured appendicitis | 2.0 | 18 | Citations (PDF) |
| 178 | The effects of weight change on glomerular filtration rate | 0.8 | 23 | Citations (PDF) |
| 179 | The Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial | 1.4 | 49 | Citations (PDF) |
| 180 | Ferric Citrate Reduces Intravenous Iron and Erythropoiesis-Stimulating Agent Use in ESRD | 0.4 | 101 | Citations (PDF) |
| 181 | Light-Intensity Physical Activities and Mortality in the United States General Population and CKD Subpopulation | 4.2 | 132 | Citations (PDF) |
| 182 | Long-term Effects of Frequent Nocturnal Hemodialysis on Mortality: The Frequent Hemodialysis Network (FHN) Nocturnal Trial | 1.4 | 107 | Citations (PDF) |
| 183 | Longitudinal changes in hematocrit in hypertensive chronic kidney disease: results from the African-American Study of Kidney Disease and Hypertension (AASK) | 0.8 | 10 | Citations (PDF) |
| 184 | Trends in Antibiotic Use and Nosocomial Pathogens in Hospitalized Veterans With Pneumonia at 128 Medical Centers, 2006–2010 | 5.2 | 79 | Citations (PDF) |
| 185 | The effect of location and configuration on forearm and upper arm hemodialysis arteriovenous grafts | 1.8 | 36 | Citations (PDF) |
| 186 | Epoprostenol Does Not Affect Mortality in Neonates with Congenital Diaphragmatic Hernia | 1.5 | 15 | Citations (PDF) |
| 187 | Interstate Variation in Receipt of Nephrologist Care in US Patients Approaching ESRD | 4.2 | 22 | Citations (PDF) |
| 188 | Estimating Time to ESRD Using Kidney Failure Risk Equations: Results From the African American Study of Kidney Disease and Hypertension (AASK) | 1.4 | 52 | Citations (PDF) |
| 189 | Variation in pediatric outpatient adenotonsillectomy costs in a multihospital network | 1.4 | 31 | Citations (PDF) |
| 190 | Ferric Citrate Controls Phosphorus and Delivers Iron in Patients on Dialysis | 0.4 | 188 | Citations (PDF) |
| 191 | Evaluating Transmission Dynamics of Methicillin-Resistant Staphylococcus aureus Across Veterans Affairs Acute Care Facilities | 0.8 | 0 | Citations (PDF) |
| 192 | 242Stewardship in Community Hospitals–Optimizing Outcomes and Resources (SCORE): A Baseline Analysis of Antimicrobial Use Utilizing CDC NHSN AU Data | 0.8 | 0 | Citations (PDF) |
| 193 | 294A Hierarchical Transmission Model Evaluating the Effectiveness of Hospital Infection Control Strategies | 0.8 | 0 | Citations (PDF) |
| 194 | Associations of Body Size and Body Composition with Functional Ability and Quality of Life in Hemodialysis Patients | 4.2 | 64 | Citations (PDF) |
| 195 | Relationships Between the Importation, Transmission, and Nosocomial Infections of Methicillin-Resistant Staphylococcus aureus: An Observational Study of 112 Veterans Affairs Medical Centers | 5.2 | 30 | Citations (PDF) |
| 196 | Risk Factors for Placenta Accreta: A Large Prospective Cohort | 1.6 | 121 | Citations (PDF) |
| 197 | Quality of Life and Outcomes in African Americans with CKD | 0.4 | 35 | Citations (PDF) |
| 198 | Effects of daily hemodialysis on heart rate variability: results from the Frequent Hemodialysis Network (FHN) Daily Trial | 0.8 | 55 | Citations (PDF) |
| 199 | Utility and Validity of Estimated GFR–Based Surrogate Time-to-Event End Points in CKD: A Simulation Study | 1.4 | 66 | Citations (PDF) |
| 200 | GFR Decline as an Alternative End Point to Kidney Failure in Clinical Trials: A Meta-analysis of Treatment Effects From 37 Randomized Trials | 1.4 | 137 | Citations (PDF) |
| 201 | GFR Decline as an End Point for Clinical Trials in CKD: A Scientific Workshop Sponsored by the National Kidney Foundation and the US Food and Drug Administration | 1.4 | 587 | Citations (PDF) |
| 202 | Improved hidden Markov model for nosocomial infections | 1.3 | 1 | Citations (PDF) |
| 203 | Response-based therapy for ruptured appendicitis reduces resource utilization | 2.0 | 36 | Citations (PDF) |
| 204 | A Within-Patient Analysis for Time-Varying Risk Factors of CKD Progression | 0.4 | 24 | Citations (PDF) |
| 205 | Decompressive craniectomy or medical management for refractory intracranial hypertension | 2.4 | 38 | Citations (PDF) |
| 206 | Race/Ethnicity, Age, and Risk of Hospital Admission and Length of Stay during the First Year of Maintenance Hemodialysis | 4.2 | 27 | Citations (PDF) |
| 207 | Association of Kidney Disease Outcomes With Risk Factors for CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study | 1.4 | 128 | Citations (PDF) |
| 208 | Early Change in Proteinuria as a Surrogate End Point for Kidney Disease Progression: An Individual Patient Meta-analysis | 1.4 | 125 | Citations (PDF) |
| 209 | Objectives and Design of the Hemodialysis Fistula Maturation Study | 1.4 | 140 | Citations (PDF) |
| 210 | Atrial Fibrillation Ablation Outcome Is Predicted by Left Atrial Remodeling on MRI | 6.1 | 378 | Citations (PDF) |
| 211 | Low-Back Pain Ratings for Lifetime, 1-Month Period, and Point Prevalences in a Large Occupational Population | 3.6 | 37 | Citations (PDF) |
| 212 | Cardiac Stress Testing During Workup for Abdominal Aortic Aneurysm Repair Does Not Improve Patient Outcomes | 1.8 | 0 | Citations (PDF) |
| 213 | Prevalence of and risk factors for reduced serum bicarbonate in chronic kidney disease | 1.6 | 92 | Citations (PDF) |
| 214 | Estimated GFR Decline as a Surrogate End Point for Kidney Failure: A Post Hoc Analysis From the Reduction of End Points in Non–Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan (RENAAL) Study and Irbesartan Diabetic Nephropathy Trial (IDNT) | 1.4 | 65 | Citations (PDF) |
| 215 | Effect of decreased parenteral soybean lipid emulsion on hepatic function in infants at risk for parenteral nutrition-associated liver disease: A pilot study | 2.0 | 86 | Citations (PDF) |
| 216 | Improved equation for estimating single-pool Kt/V at higher dialysis frequencies | 0.8 | 52 | Citations (PDF) |
| 217 | Serum bicarbonate and mortality in adults in NHANES III | 0.8 | 98 | Citations (PDF) |
| 218 | A Trial of 2 Strategies to Reduce Nocturnal Blood Pressure in Blacks With Chronic Kidney Disease | 6.6 | 90 | Citations (PDF) |
| 219 | Gabapentin Versus Chlordiazepoxide for Outpatient Alcohol Detoxification Treatment | 2.1 | 40 | Citations (PDF) |
| 220 | Longitudinal Validation of a Tool for Asthma Self-Monitoring | 4.5 | 17 | Citations (PDF) |
| 221 | Facility Size, Race and Ethnicity, and Mortality for In-Center Hemodialysis | 0.4 | 17 | Citations (PDF) |
| 222 | Effects of Frequent Hemodialysis on Ventricular Volumes and Left Ventricular Remodeling | 4.2 | 81 | Citations (PDF) |
| 223 | Decreasing Hospital Length of Stay for Bronchiolitis by Using an Observation Unit and Home Oxygen Therapy | 8.5 | 39 | Citations (PDF) |
| 224 | The Relationship of Age, Race, and Ethnicity with Survival in Dialysis Patients | 4.2 | 80 | Citations (PDF) |
| 225 | Association of Histologic Variants in FSGS Clinical Trial with Presenting Features and Outcomes | 4.2 | 151 | Citations (PDF) |
| 226 | Reply to Comment on “Gabapentin Versus Chlordiazepoxide for Outpatient Alcohol Detoxification Treatment” | 2.1 | 2 | Citations (PDF) |
| 227 | Renal Function and Proteinuria after Successful Immunosuppressive Therapies in Patients with FSGS | 4.2 | 20 | Citations (PDF) |
| 228 | Relationship of Left Ventricular Hypertrophy and Diastolic Function With Cardiovascular and Renal Outcomes in African Americans With Hypertensive Chronic Kidney Disease | 6.6 | 52 | Citations (PDF) |
| 229 | Associations of Serum Skeletal Alkaline Phosphatase with Elevated C-Reactive Protein and Mortality | 4.2 | 45 | Citations (PDF) |
| 230 | Effect of frequent hemodialysis on residual kidney function | 5.3 | 210 | Citations (PDF) |
| 231 | APOL1
Risk Variants, Race, and Progression of Chronic Kidney Disease | 34.5 | 779 | Citations (PDF) |
| 232 | The Associations between Race and Geographic Area and Quality-of-Care Indicators in Patients Approaching ESRD | 4.2 | 58 | Citations (PDF) |
| 233 | The Balanced Survivor Average Causal Effect | 1.2 | 5 | Citations (PDF) |
| 234 | A Weighting Analogue to Pair Matching in Propensity Score Analysis | 1.2 | 315 | Citations (PDF) |
| 235 | Visit-to-visit systolic blood pressure variability and outcomes in hemodialysis | 2.5 | 68 | Citations (PDF) |
| 236 | Design of Clinical Trials in AKI | 4.2 | 40 | Citations (PDF) |
| 237 | Determinants of Left Ventricular Mass in Patients on Hemodialysis | 2.9 | 98 | Citations (PDF) |
| 238 | Design of Clinical Trials in Acute Kidney Injury | 4.2 | 156 | Citations (PDF) |
| 239 | Relationship between Ambulatory BP and Clinical Outcomes in Patients with Hypertensive CKD | 4.2 | 84 | Citations (PDF) |
| 240 | A Lower Extremity Physical Function Computerized Adaptive Testing Instrument for Orthopaedic Patients | 2.4 | 59 | Citations (PDF) |
| 241 | Pyridorin in Type 2 Diabetic Nephropathy | 0.4 | 140 | Citations (PDF) |
| 242 | The effect of frequent hemodialysis on nutrition and body composition: Frequent Hemodialysis Network Trial | 5.3 | 79 | Citations (PDF) |
| 243 | Racial Differences in Markers of Mineral Metabolism in Advanced Chronic Kidney Disease | 4.2 | 34 | Citations (PDF) |
| 244 | New Paradigm for Patient-Reported Outcomes Assessment in Foot & Ankle Research: Computerized Adaptive Testing | 2.4 | 78 | Citations (PDF) |
| 245 | The Joint Commission Children’s Asthma Care Quality Measures and Asthma Readmissions | 4.5 | 66 | Citations (PDF) |
| 246 | High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney disease | 5.3 | 376 | Citations (PDF) |
| 247 | Agreement in Classifying Bloodstream Infections Among Multiple Reviewers Conducting Surveillance | 5.2 | 75 | Citations (PDF) |
| 248 | Design of Clinical Trials in Acute Kidney Injury | 4.2 | 52 | Citations (PDF) |
| 249 | Estimating GFR Among Participants in the Chronic Renal Insufficiency Cohort (CRIC) Study | 1.4 | 233 | Citations (PDF) |
| 250 | Transposon insertion in a cinnamyl alcohol dehydrogenase gene is responsible for a brown midrib1 mutation in maize | 3.2 | 45 | Citations (PDF) |
| 251 | Left ventricular hypertrophy by electrocardiography and echocardiography in the African American Study of Kidney Disease Cohort Study | 2.3 | 10 | Citations (PDF) |
| 252 | Quality of life and psychosocial factors in African Americans with hypertensive chronic kidney disease | 4.0 | 37 | Citations (PDF) |
| 253 | Associations of Plasma 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D Concentrations With Death and Progression to Maintenance Dialysis in Patients With Advanced Kidney Disease | 1.4 | 73 | Citations (PDF) |
| 254 | Dietary phosphorus intake and mortality in moderate chronic kidney disease: NHANES III | 0.8 | 41 | Citations (PDF) |
| 255 | Factors associated with intern noncompliance with the 2003 Accreditation Council for Graduate Medical Education’s 30-hour duty period requirement | 2.6 | 1 | Citations (PDF) |
| 256 | Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C | 34.5 | 3,878 | Citations (PDF) |
| 257 | Nonparametric multistate representations of survival and longitudinal data with measurement error | 1.7 | 7 | Citations (PDF) |
| 258 | Kidney Function Can Improve in Patients with Hypertensive CKD | 0.4 | 55 | Citations (PDF) |
| 259 | Effects of Frequent Hemodialysis on Measures of CKD Mineral and Bone Disorder | 0.4 | 146 | Citations (PDF) |
| 260 | Longitudinal Progression Trajectory of GFR Among Patients With CKD | 1.4 | 306 | Citations (PDF) |
| 261 | 25-hydroxyvitamin D deficiency is associated with an increased risk of metabolic syndrome in patients with non-diabetic chronic kidney disease | 0.7 | 6 | Citations (PDF) |
| 262 | The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial | 5.3 | 509 | Citations (PDF) |
| 263 | Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts | 5.3 | 700 | Citations (PDF) |
| 264 | Associations of Serum Alkaline Phosphatase with Metabolic Syndrome and Mortality | 2.0 | 35 | Citations (PDF) |
| 265 | 74 Sleep Apnea (SA) is an Effect Modifier of Associations of Diabetes Mellitus (DM) on Albuminuria and Cardiovascular Disease (CVD): NHANES | 1.4 | 1 | Citations (PDF) |
| 266 | 152 Ergocalciferol (ERGO) Therapy in Calcidiol-Deficient Hemodialysis (HD) Patients on Therapeutic Doses of Paricalcitol | 1.4 | 0 | Citations (PDF) |
| 267 | Sulodexide for Kidney Protection in Type 2 Diabetes Patients With Microalbuminuria: A Randomized Controlled Trial | 1.4 | 111 | Citations (PDF) |
| 268 | Statistical analysis and design for estimating accuracy in clinical-center classification of cause-specific clinical events in clinical trials | 1.8 | 1 | Citations (PDF) |
| 269 | Evaluation of the PROMIS physical function item bank in orthopaedic patients | 2.4 | 179 | Citations (PDF) |
| 270 | Higher serum bicarbonate levels within the normal range are associated with better survival and renal outcomes in African Americans | 5.3 | 191 | Citations (PDF) |
| 271 | Modeled Urea Distribution Volume and Mortality in the HEMO Study | 4.2 | 19 | Citations (PDF) |
| 272 | Intradialytic Hypotension and Vascular Access Thrombosis | 0.4 | 204 | Citations (PDF) |
| 273 | Equations to Estimate Creatinine Excretion Rate | 4.2 | 189 | Citations (PDF) |
| 274 | Use of Aspirin Associates with Longer Primary Patency of Hemodialysis Grafts | 0.4 | 46 | Citations (PDF) |
| 275 | Early change in proteinuria as a surrogate outcome in kidney disease progression: a systematic review of previous analyses and creation of a patient-level pooled dataset | 0.8 | 23 | Citations (PDF) |
| 276 | FGF-23 Associates with Death, Cardiovascular Events, and Initiation of Chronic Dialysis | 0.4 | 444 | Citations (PDF) |
| 277 | Limitations of Analyses Based on Achieved Blood Pressure | 6.6 | 43 | Citations (PDF) |
| 278 | Changes in dietary protein intake has no effect on serum cystatin C levels independent of the glomerular filtration rate | 5.3 | 168 | Citations (PDF) |
| 279 | Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of life | 5.3 | 59 | Citations (PDF) |
| 280 | Serum alkaline phosphatase levels associate with elevated serum C-reactive protein in chronic kidney disease | 5.3 | 66 | Citations (PDF) |
| 281 | Elevated depressive affect is associated with adverse cardiovascular outcomes among African Americans with chronic kidney disease | 5.3 | 49 | Citations (PDF) |
| 282 | Clinical trial of focal segmental glomerulosclerosis in children and young adults | 5.3 | 233 | Citations (PDF) |
| 283 | Predicting sites of ADAR editing in double-stranded RNA | 13.7 | 363 | Citations (PDF) |
| 284 | 75: Assocations of Serum Alkaline Phosphatase With Elevated CRP in Chronic Kidney Disease Are Independent of Serum 25 OH Vitamin D Levels | 1.4 | 0 | Citations (PDF) |
| 285 | 286: Iron Absorption With Higher Doses of Ferric Citrate in Controlling Serum Phosphorus in ESRD Patients | 1.4 | 0 | Citations (PDF) |
| 286 | 287: The Safety and Tolerability of Higher Doses of Ferric Citrate (FC) in Controlling Serum Phosphorus (P) In ESRD Patients | 1.4 | 0 | Citations (PDF) |
| 287 | Imprecision of Urinary Iothalamate Clearance as a Gold-Standard Measure of GFR Decreases the Diagnostic Accuracy of Kidney Function Estimating Equations | 1.4 | 121 | Citations (PDF) |
| 288 | Serum Bicarbonate and Long-term Outcomes in CKD | 1.4 | 121 | Citations (PDF) |
| 289 | Comparative Performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study Equations for Estimating GFR Levels Above 60 mL/min/1.73 m2 | 1.4 | 560 | Citations (PDF) |
| 290 | Relationship Between Body Mass Index and Proteinuria in Hypertensive Nephrosclerosis: Results From the African American Study of Kidney Disease and Hypertension (AASK) Cohort | 1.4 | 49 | Citations (PDF) |
| 291 | Insight: Effects of Reduced Intradialytic Urea Generation Rate and Residual Renal Clearance on Modeled Urea Distribution Volume and Kt/V in Conventional, Daily, and Nocturnal Dialysis | 1.0 | 7 | Citations (PDF) |
| 292 | Updated comorbidity assessments and outcomes in prevalent hemodialysis patients | 1.1 | 9 | Citations (PDF) |
| 293 | Hyperlipidemia and Long-Term Outcomes in Nondiabetic Chronic Kidney Disease | 4.2 | 82 | Citations (PDF) |
| 294 | Can Rescaling Dose of Dialysis to Body Surface Area in the HEMO Study Explain the Different Responses to Dose in Women versus Men? | 4.2 | 69 | Citations (PDF) |
| 295 | Malnutrition-Inflammation Modifies the Relationship of Cholesterol with Cardiovascular Disease | 0.4 | 47 | Citations (PDF) |
| 296 | Rate of ESRD Exceeds Mortality among African Americans with Hypertensive Nephrosclerosis | 0.4 | 49 | Citations (PDF) |
| 297 | Development and validation of GFR-estimating equations using diabetes, transplant and weight | 0.8 | 121 | Citations (PDF) |
| 298 | In-Center Hemodialysis Six Times per Week versus Three Times per Week | 34.5 | 989 | Citations (PDF) |
| 299 | Standard Kt/Vurea: a method of calculation that includes effects of fluid removal and residual kidney clearance | 5.3 | 98 | Citations (PDF) |
| 300 | Sociodemographic factors contribute to the depressive affect among African Americans with chronic kidney disease | 5.3 | 63 | Citations (PDF) |
| 301 | Intensive Blood-Pressure Control in Hypertensive Chronic Kidney Disease | 34.5 | 695 | Citations (PDF) |
| 302 | Systolic blood pressure and mortality in prevalent haemodialysis patients in the HEMO study | 2.5 | 48 | Citations (PDF) |
| 303 | Associations of resting heart rate with insulin resistance, cardiovascular events and mortality in chronic kidney disease | 0.8 | 45 | Citations (PDF) |
| 304 | Effect of Dipyridamole plus Aspirin on Hemodialysis Graft Patency | 34.5 | 284 | Citations (PDF) |
| 305 | Scaling of Measured Glomerular Filtration Rate in Kidney Donor Candidates by Anthropometric Estimates of Body Surface Area, Body Water, Metabolic Rate, or Liver Size | 4.2 | 36 | Citations (PDF) |
| 306 | Serum Alkaline Phosphatase and Mortality in African Americans with Chronic Kidney Disease | 4.2 | 74 | Citations (PDF) |
| 307 | Disparate Estimates of Hypertension Control From Ambulatory and Clinic Blood Pressure Measurements in Hypertensive Kidney Disease | 6.6 | 269 | Citations (PDF) |
| 308 | Asymmetric Dimethylarginine and Mortality in Stages 3 to 4 Chronic Kidney Disease | 4.2 | 91 | Citations (PDF) |
| 309 | Usefulness of Adjusting for Clinical Covariates to Improve the Ability of B-Type Natriuretic Peptide to Distinguish Cardiac from Noncardiac Dyspnea | 1.8 | 29 | Citations (PDF) |
| 310 | Effect of a Very Low-Protein Diet on Outcomes: Long-term Follow-up of the Modification of Diet in Renal Disease (MDRD) Study | 1.4 | 244 | Citations (PDF) |
| 311 | Randomized and Observational Studies in Nephrology: How Strong Is the Evidence? | 1.4 | 32 | Citations (PDF) |
| 312 | Uric Acid and Long-term Outcomes in CKD | 1.4 | 394 | Citations (PDF) |
| 313 | Solute Clearances and Fluid Removal in the Frequent Hemodialysis Network Trials | 1.4 | 41 | Citations (PDF) |
| 314 | Related Causal Frameworks for Surrogate Outcomes | 1.6 | 172 | Citations (PDF) |
| 315 | A Semiparametric Joint Model for Longitudinal and Survival Data with Application to Hemodialysis Study | 1.6 | 19 | Citations (PDF) |
| 316 | Physical Activity and Mortality in Chronic Kidney Disease (NHANES III) | 4.2 | 303 | Citations (PDF) |
| 317 | A New Equation to Estimate Glomerular Filtration Rate | 9.6 | 23,751 | Citations (PDF) |
| 318 | Factors other than glomerular filtration rate affect serum cystatin C levels | 5.3 | 737 | Citations (PDF) |
| 319 | Investigating the effects of ties on measures of concordance | 1.7 | 21 | Citations (PDF) |
| 320 | Efficient Estimation for Patient-Specific Rates of Disease Progression Using Nonnormal Linear Mixed Models | 1.6 | 28 | Citations (PDF) |
| 321 | Varying Coefficients Model with Measurement Error | 1.6 | 36 | Citations (PDF) |
| 322 | Dialysis Research: Surface‐Area‐Normalized Kt/V: A Method of Rescaling Dialysis Dose to Body Surface Area—Implications for Different‐Size Patients by Gender | 1.0 | 60 | Citations (PDF) |
| 323 | The Influence of Age on Changes in Health‐Related Quality of Life over Three Years in a Cohort Undergoing Hemodialysis | 2.9 | 75 | Citations (PDF) |
| 324 | Estimating GFR Using Serum Cystatin C Alone and in Combination With Serum Creatinine: A Pooled Analysis of 3,418 Individuals With CKD | 1.4 | 995 | Citations (PDF) |
| 325 | 68: Risk Factors for Accelerated Loss of GFR in Advanced Chronic Kidney Disease (CKD) | 1.4 | 0 | Citations (PDF) |
| 326 | A Comparison of Change in Measured and Estimated Glomerular Filtration Rate in Patients with Nondiabetic Kidney Disease | 4.2 | 70 | Citations (PDF) |
| 327 | Dosing intermittent haemodialysis in the intensive care unit patient with acute renal failure--estimation of urea removal and evidence for the regional blood flow model | 0.8 | 16 | Citations (PDF) |
| 328 | Effects of sulodexide in patients with type 2 diabetes and persistent albuminuria | 0.8 | 57 | Citations (PDF) |
| 329 | Association between Serum β2-Microglobulin Level and Infectious Mortality in Hemodialysis Patients | 4.2 | 88 | Citations (PDF) |
| 330 | Long-term outcomes in nondiabetic chronic kidney disease | 5.3 | 72 | Citations (PDF) |
| 331 | Effect of Clopidogrel on Early Failure of Arteriovenous Fistulas for Hemodialysis | 16.5 | 790 | Citations (PDF) |
| 332 | Long-term Effects of Renin-Angiotensin System–Blocking Therapy and a Low Blood Pressure Goal on Progression of Hypertensive Chronic Kidney Disease in African Americans | 8.1 | 156 | Citations (PDF) |
| 333 | A well-conducted randomized trial that establishes no benefit of therapy is an important medical advance | 0.8 | 4 | Citations (PDF) |
| 334 | Fetuin-A is not associated with mortality in chronic kidney disease | 5.3 | 33 | Citations (PDF) |
| 335 | Cystatin C as a Risk Factor for Outcomes in Chronic Kidney Disease | 9.6 | 181 | Citations (PDF) |
| 336 | A Simulation-Based Evaluation of Methods to Estimate the Impact of an Adverse Event on Hospital Length of Stay | 1.8 | 25 | Citations (PDF) |
| 337 | Inflammation and Inverse Associations of Body Mass Index and Serum Creatinine With Mortality in Hemodialysis Patients 2007, 17, 372-380 | | 42 | Citations (PDF) |
| 338 | Expressing the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate with Standardized Serum Creatinine Values | 1.1 | 1,745 | Citations (PDF) |
| 339 | Role of Adipose Tissue in Determining Muscle Mass in Patients With Chronic Kidney Disease 2007, 17, 314-322 | | 21 | Citations (PDF) |
| 340 | Impact of Creatinine Calibration on Performance of GFR Estimating Equations in a Pooled Individual Patient Database | 1.4 | 206 | Citations (PDF) |
| 341 | Body Mass Index and Mortality in CKD | 1.4 | 64 | Citations (PDF) |
| 342 | Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate | 34.5 | 2,755 | Citations (PDF) |
| 343 | Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate | 9.6 | 5,056 | Citations (PDF) |
| 344 | Shared parameter models for the joint analysis of longitudinal data and event times | 1.7 | 154 | Citations (PDF) |
| 345 | Resistance to intercompartmental mass transfer limits β2-microglobulin removal by post-dilution hemodiafiltration | 5.3 | 130 | Citations (PDF) |
| 346 | Effect of Change in Vascular Access on Patient Mortality in Hemodialysis Patients | 1.4 | 200 | Citations (PDF) |
| 347 | Quality of Life in the African American Study of Kidney Disease and Hypertension: Effects of Blood Pressure Management | 1.4 | 20 | Citations (PDF) |
| 348 | Cardiovascular Outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial | 1.4 | 144 | Citations (PDF) |
| 349 | Effect of Dietary Protein Restriction on the Progression of Kidney Disease: Long-Term Follow-Up of the Modification of Diet in Renal Disease (MDRD) Study | 1.4 | 152 | Citations (PDF) |
| 350 | Relationship Between Homocysteine and Mortality in Chronic Kidney Disease | 18.0 | 57 | Citations (PDF) |
| 351 | Response to Letter Regarding Article, “Relationship Between Homocysteine and Mortality in Chronic Kidney Disease” | 18.0 | 0 | Citations (PDF) |
| 352 | Daily Hemodialysis | 4.2 | 167 | Citations (PDF) |
| 353 | Effect of Dietary Protein Intake on Serum Total CO2 Concentration in Chronic Kidney Disease: Modification of Diet in Renal Disease Study Findings | 4.2 | 56 | Citations (PDF) |
| 354 | Surrogate End Points for Clinical Trials of Kidney Disease Progression | 4.2 | 125 | Citations (PDF) |
| 355 | Recommendations for Improving Serum Creatinine Measurement: A Report from the Laboratory Working Group of the National Kidney Disease Education Program | 1.1 | 1,142 | Citations (PDF) |
| 356 | The Effect of a Lower Target Blood Pressure on the Progression of Kidney Disease: Long-Term Follow-up of the Modification of Diet in Renal Disease Study | 9.6 | 478 | Citations (PDF) |
| 357 | Homocysteine in chronic kidney disease: Effect of low protein diet and repletion with B vitamins | 5.3 | 34 | Citations (PDF) |
| 358 | C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease | 5.3 | 369 | Citations (PDF) |
| 359 | Are nutritional status indicators associated with mortality in the Hemodialysis (HEMO) Study? | 5.3 | 104 | Citations (PDF) |
| 360 | Performance of the Cockcroft-Gault and Modification of Diet in Renal Disease Equations in Estimating GFR in Ill Hospitalized Patients | 1.4 | 204 | Citations (PDF) |
| 361 | Relationship of Phosphorus and Calcium-Phosphorus Product With Mortality in CKD | 1.4 | 120 | Citations (PDF) |
| 362 | Low-Level Environmental Lead Exposure and Children’s Intellectual Function: An International Pooled Analysis | 8.3 | 1,983 | Citations (PDF) |
| 363 | Design of the Dialysis Access Consortium (DAC) Aggrenox prevention of access stenosis trial | 1.8 | 29 | Citations (PDF) |
| 364 | Design of the Dialysis Access Consortium (DAC) clopidogrel prevention of early AV fistula thrombosis trial | 1.8 | 49 | Citations (PDF) |
| 365 | The Relationship Between Magnitude of Proteinuria Reduction and Risk of End-stage Renal Disease | 8.1 | 275 | Citations (PDF) |
| 366 | Blood Pressure Control, Drug Therapy, and Kidney Disease | 6.6 | 35 | Citations (PDF) |
| 367 | The HEMO Study: applicability and generalizability | 0.8 | 21 | Citations (PDF) |
| 368 | Self-reported appetite, hospitalization and death in haemodialysis patients: findings from the Hemodialysis (HEMO) Study | 0.8 | 127 | Citations (PDF) |
| 369 | Dialysis dose as a determinant of adequacy | 2.3 | 8 | Citations (PDF) |
| 370 | Target Blood Pressure and Kidney Disease | 9.6 | 2 | Citations (PDF) |
| 371 | Dialysis dose and the effect of gender and body size on outcome in the HEMO Study | 5.3 | 158 | Citations (PDF) |
| 372 | The effect of dialysis dose and membrane flux on nutritional parameters in hemodialysis patients: Results of the HEMO Study | 5.3 | 129 | Citations (PDF) |
| 373 | Effects of hemodialysis dose and membrane flux on health-related quality of life in the HEMO Study | 5.3 | 161 | Citations (PDF) |
| 374 | Kinetics of urea and β2-microglobulin during and after short hemodialysis treatments | 5.3 | 37 | Citations (PDF) |
| 375 | Reply from the Authors | 5.3 | 0 | Citations (PDF) |
| 376 | Dialyzer Performance in the HEMO Study:In Vivo K 0 A and True Blood Flow Determined from a Model of Cross-Dialyzer Urea Extraction | 1.8 | 41 | Citations (PDF) |
| 377 | Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third national health and nutrition examination survey | 1.4 | 2,293 | Citations (PDF) |
| 378 | Longitudinal and cross-sectional effects of C-reactive protein, equilibrated normalized protein catabolic rate, and serum bicarbonate on creatinine and albumin levels in dialysis patients | 1.4 | 91 | Citations (PDF) |
| 379 | High urine volume and low urine osmolality are risk factors for faster progression of renal disease | 1.4 | 130 | Citations (PDF) |
| 380 | Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease | 1.4 | 167 | Citations (PDF) |
| 381 | Anthropometrically estimated total body water volumes are larger than modeled urea volume in chronic hemodialysis patients: Effects of age, race, and gender | 5.3 | 74 | Citations (PDF) |
| 382 | Prescribing an equilibrated intermittent hemodialysis dose in intensive care unit acute renal failure | 5.3 | 35 | Citations (PDF) |
| 383 | Efecto preventivo de la disminución de las cifras de presión arterial y los antihipertensivos en la nefropatía hipertensiva | 0.0 | 0 | Citations (PDF) |
| 384 | Seasonal Variations in Clinical and Laboratory Variables among Chronic Hemodialysis Patients | 0.4 | 102 | Citations (PDF) |
| 385 | Successful Blood Pressure Control in the African American Study of Kidney Disease and Hypertension | 8.1 | 125 | Citations (PDF) |
| 386 | Effect of Blood Pressure Lowering and Antihypertensive Drug Class on Progression of Hypertensive Kidney DiseaseResults From the AASK Trial | 16.5 | 1,928 | Citations (PDF) |
| 387 | Effect of Dialysis Dose and Membrane Flux in Maintenance Hemodialysis | 34.5 | 1,777 | Citations (PDF) |
| 388 | Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate | 1.4 | 691 | Citations (PDF) |
| 389 | Homocysteine, cysteine, and B vitamins as predictors of kidney disease progression | 1.4 | 41 | Citations (PDF) |
| 390 | Serum C-reactive protein and leptin as predictors of kidney disease progression in the Modification of Diet in Renal Disease Study | 5.3 | 76 | Citations (PDF) |
| 391 | Mathematical Coupling and the Association Between Kt/V and PCRn | 1.0 | 3 | Citations (PDF) |
| 392 | Analysis of change in the presence of informative censoring: application to a longitudinal clinical trial of progressive renal disease | 1.7 | 49 | Citations (PDF) |
| 393 | A Model for a Proportional Treatment Effect on Disease Progression | 1.6 | 15 | Citations (PDF) |
| 394 | Relationship between nutritional status and the glomerular filtration rate: Results from the MDRD Study | 5.3 | 360 | Citations (PDF) |
| 395 | Design and Statistical Issues of the Hemodialysis (HEMO) Study | 2.8 | 130 | Citations (PDF) |
| 396 | Factors associated with the prevalence of arteriovenous fistulas in hemodialysis patients in the HEMO Study | 5.3 | 189 | Citations (PDF) |
| 397 | Imprecision of the hemodialysis dose when measured directly from urea removal | 5.3 | 38 | Citations (PDF) |
| 398 | Relationship between apparent (single-pool) and true (double-pool) urea distribution volume | 5.3 | 46 | Citations (PDF) |
| 399 | A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation | 9.6 | 14,022 | Citations (PDF) |
| 400 | Dietary Protein Restriction and the Progression of Chronic Renal Disease | 0.4 | 370 | Citations (PDF) |
| 401 | Prediction Equation for Glomerular Filtration Rate | 9.6 | 0 | Citations (PDF) |
| 402 | Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study | 5.3 | 626 | Citations (PDF) |
| 403 | Hemodialyzer mass transfer-area coefficients for urea increase at high dialysate flow rates | 5.3 | 151 | Citations (PDF) |
| 404 | Effect of dietary protein restriction on nutritional status in the Modification of Diet in Renal Disease Study | 5.3 | 203 | Citations (PDF) |
| 405 | Comparison of methods to predict equilibrated Kt/V in the HEMO Pilot Study | 5.3 | 154 | Citations (PDF) |
| 406 | Achievement and Safety of a Low Blood Pressure Goal in Chronic Renal Disease | 6.6 | 197 | Citations (PDF) |
| 407 | Effects of Blood Pressure Control on Progressive Renal Disease in Blacks and Whites | 6.6 | 134 | Citations (PDF) |
| 408 | Cerebrospinal fluid drainage and distal aortic perfusion: Reducing neurologic complications in repair of thoracoabdominal aortic aneurysm types I and II | 1.8 | 200 | Citations (PDF) |
| 409 | Effects of dietary protein restriction on the progression of advanced renal disease in the modification of diet in renal disease study | 1.4 | 319 | Citations (PDF) |
| 410 | Toxocara canis infection in preschool age children: Risk factors and the cognitive development of preschool children | 1.5 | 41 | Citations (PDF) |
| 411 | Blood Pressure Control, Proteinuria, and the Progression of Renal Disease | 9.6 | 1,217 | Citations (PDF) |
| 412 | Neonatal Diagnosis of Fetal Alcohol Syndrome: Not Necessarily a Hopeless Prognosis | 2.5 | 17 | Citations (PDF) |
| 413 | Histometric effects of ciliary neurotrophic factor in wobbler mouse motor neuron disease | 6.6 | 51 | Citations (PDF) |
| 414 | Effects of brain‐derived neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease | 6.6 | 133 | Citations (PDF) |
| 415 | 56A Comparison of time-to-event and slope-based analyses in nephrology clinical trials | 2.8 | 1 | Citations (PDF) |
| 416 | The effects of ciliary neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease | 6.6 | 132 | Citations (PDF) |
| 417 | 03A Recruitment sampling strategy and power analyses in the MMHD study | 2.8 | 0 | Citations (PDF) |
| 418 | Serum Lipid Changes Associated With Modified Protein Diets: Results From the Feasibility Phase of the Modification of Diet in Renal Disease Study | 1.4 | 14 | Citations (PDF) |
| 419 | Dentine lead and intelligence prior to school entry: A statistical sensitivity analysis | 3.6 | 19 | Citations (PDF) |
| 420 | Response | 3.6 | 2 | Citations (PDF) |
| 421 | Reply | 8.3 | 0 | Citations (PDF) |
| 422 | Postpartum changes in maternal blood lead concentrations. | 2.8 | 8 | Citations (PDF) |
| 423 | Contributions of risk factors to elevated blood and dentine lead levels in preschool children | 8.3 | 16 | Citations (PDF) |
| 424 | Adjustment for Cofactors in Pediatric Research | 1.7 | 14 | Citations (PDF) |
| 425 | Covariance pooling and stabilization for classification | 1.4 | 42 | Citations (PDF) |
| 426 | Prenatal alcohol exposure and sustained attention in the preschool years | 1.5 | 58 | Citations (PDF) |
| 427 | Prenatal alcohol exposure and cognitive development in the preschool years | 1.5 | 64 | Citations (PDF) |
| 428 | Prenatal and preschool age lead exposure: Relationship with size | 1.5 | 55 | Citations (PDF) |
| 429 | Descriptively sufficient subcollections of flats in matroids | 0.7 | 8 | Citations (PDF) |
| 430 | Prenatal Alcohol Exposure and Preschool Physical Growth: A Longitudinal Analysis | 2.5 | 35 | Citations (PDF) |
| 431 | Prenatal Alcohol Exposure and Language Development | 2.5 | 69 | Citations (PDF) |
| 432 | The depiction of linear association by matroids | 1.4 | 1 | Citations (PDF) |
| 433 | Low-Level Lead Exposure in the Prenatal and Early Preschool Periods: Language Development | 0.1 | 28 | Citations (PDF) |
| 434 | Partially pooled covariance matrix estimation in discriminant analysis | 1.3 | 34 | Citations (PDF) |
| 435 | A modular approach to integrating multiple data sources into real-time clinical prediction for pediatric diarrhea | 0.7 | 12 | Citations (PDF) |
| 436 | Title is missing! 0 | | 1 | Citations (PDF) |
| 437 | Decline in glomerular filtration rate as an endpoint in heart failure clinical trials: challenges and solutions | 2.2 | 6 | Citations (PDF) |
| 438 | Considerations for Using eGFR Slope as an End Point in Clinical Trials | 0.4 | 2 | Citations (PDF) |
| 439 | Albuminuria Change as a Surrogate End Point for Kidney Failure: An Updated Meta-Analysis of Randomised Controlled Trials | 0.4 | 0 | Citations (PDF) |
| 440 | Impact of a Smartwatch Hypertension Notification Feature for Population Screening | 16.5 | 3 | Citations (PDF) |
| 441 | WCN26-4393 CLINICAL AND NON-CLINICAL RISK FACTORS FOR INCIDENT CHRONIC KIDNEY DISEASE (CKD): ANALYSIS OF US NATIONWIDE PRE-CKD VETERAN POPULATION | 2.5 | 0 | Citations (PDF) |
| 442 | Implications of acute change in estimated Glomerular Filtration Rate (eGFR) for the effect of sodium-glucose cotransporter-2 inhibitors (SGLT-2i) on long-term endpoints | 2.3 | 0 | Citations (PDF) |
| 443 | 1000 Effects of a Behavioral Sleep Extension Intervention on Sleep, Patient Reported Outcomes and Cardiometabolic Health Outcomes over 12 Months | 0.9 | 0 | Citations (PDF) |
| 444 | Actigraphic estimates of sleep duration in those reporting sleeping less than 7 h | 2.8 | 1 | Citations (PDF) |
| 445 | Backward joint model for the joint dynamic prediction of time-to-event and longitudinal data: basic formulation and new developments | 0.8 | 0 | Citations (PDF) |
